Boston Scientific's Global Expansion: What's Behind the Growth?

Key Takeaways BSX focuses on expanding its global presence, with EMEA, APAC and Latin America at 35% of 2025 revenues.BSX is globalizing R&D from a largely U.S.-based model, accelerating product development worldwide.BSX's Interventional Cardiology business generates nearly 70% of revenues from overseas markets.Boston Scientific (BSX) focuses on expanding its global presence to pursue growth opportunities in net sales and market share outside the United States. This includes Emerging Markets, defined as all ...